TransMedics Group, Inc. (TMDX)
Latest news, insights and market data
Market Data
$0.00
$76.51 (-100.00%)
Previous Close: $76.51
52-Week Range
0% from low
$64.85$83.29
AI Insights
No news
Updated about 2 hours ago
Latest News
| Title | Published |
|---|---|
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | about 12 hours ago |
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline | 6 days ago |
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference | 6 days ago |
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for | 7 days ago |
UBS Initiates TransMedics Group at Neutral With $80 Price Target UBS Initiates TransMedics Group at Neutral With $80 Price Target | 7 days ago |
TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum TransMedics Group (TMDX) combines strong earnings growth with a reasonable valuation, making it an affordable growth play in medical technology. | 7 days ago |
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 | 13 days ago |
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
about 12 hours ago
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline
6 days ago
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
6 days ago
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for
7 days ago
UBS Initiates TransMedics Group at Neutral With $80 Price Target
UBS Initiates TransMedics Group at Neutral With $80 Price Target
7 days ago
TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum
TransMedics Group (TMDX) combines strong earnings growth with a reasonable valuation, making it an affordable growth play in medical technology.
7 days ago
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
13 days ago